About Changzhou No.2 People's Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Changzhou No.2 People's Hospital
During the past decade, Changzhou No.2 People's Hospital conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 9 clinical trials were completed, i.e. on
average, 22% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 8 clinical trials were completed. i.e. 26.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Changzhou No.2 People's Hospital" #1 sponsor was "Eli Lilly and Company" with 13 trials, followed by "The First Affiliated Hospital with Nanjing Medical University" with 6 trials
sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "BeiGene" with 2 trials sponsored and "Jinling Hospital, China"
with 2 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Changzhou No.2 People's Hospital"
#1 collaborator was "Huazhong University of Science and Technology" with 2 trials as a collaborator, "Affiliated Hospital of Nantong University" with 1 trials as a collaborator, "Anhui Provincial Hospital" with 1 trials as a collaborator, "Baotou Central Hospital" with 1 trials as a collaborator and "Central Hospital of Minhang District, Shanghai" with 1 trials as a collaborator. Other collaborators include 66 different institutions and companies that were
collaborators in the rest 76 trials.
Clinical Trials Conditions at Changzhou No.2 People's Hospital
According to Clinical.Site data, the most researched conditions in "Changzhou No.2 People's Hospital" are
"Colorectal Cancer" (4 trials), "Crohn's Disease" (3 trials), "Type 2 Diabetes" (3 trials), "Type 2 Diabetes Mellitus" (3 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Changzhou No.2 People's Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Changzhou No.2 People's Hospital
Most popular intervention types in "Changzhou No.2 People's Hospital" are "Drug" (37 trials), "Biological" (3 trials), "Device" (3 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Insulin Glargine" (4 trials), "Insulin Degludec" (3 trials), "Insulin Lispro" (3 trials) and "Tislelizumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Changzhou No.2 People's Hospital
The vast majority of trials in "Changzhou No.2 People's Hospital" are
44 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Changzhou No.2 People's Hospital
Currently, there are NaN active trials in "Changzhou No.2 People's Hospital".
1 are not yet recruiting,
16 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Changzhou No.2 People's Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Changzhou No.2 People's Hospital, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 25 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 7 trials, and there were
also 5 trials that are defined as “Not Applicable".